Cutaneous allergy to human (recombinant DNA) insulin

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 53, Issue 1, 1998, Pages 106-107

  Gonzalo, M A ^a   De Argila, D ^a   Revenga, F ^a   Garcia J M ^a   Diaz J ^a   Morales, F ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Diabetes mellitus; Drug hypersensitivity; Insulin; Recombinant proteins; Skin

Indexed keywords

20 NOVOLET; CETIRIZINE; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; NEUTRAL INSULIN; RECOMBINANT HUMAN INSULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; PRICK TEST; PRIORITY JOURNAL; PRURITUS; RASH; SKIN ALLERGY;

EID: 0031963152     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1998.tb03786.x     Document Type: Article

References (6)

1. Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 1993;16 Suppl 3:155-65.
2. Ratner RE, Phillips TM, Steiner M. Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes 1990;39:728-33.
3. Takatsuki H, Ishii H, Yamauchi T, et al. A case of insulin allergy: the crystalline human insulin may mask its antigenicity. Diabetes Res Clin Pract 1991;12:137-9.
4. Grammer LC, Metzger BE, Patterson R. Cutaneous allergy to human (recombinant DNA) insulin. JAMA 1984;251:1459-60.
5. Grammer LC, Roberts M, Buchanan TA, Fitzsimons R, Metzger BE, Patterson R. Specificity of immunoglobulin E and immunoglobulin G against human (recombinant DNA) insulin in human insulin allergy and resistance. J Lab Clin Med 1987;109:141-6.
6. Alvarez-Thull L, Rosenwasser LJ, Brodie TD. Systemic allergy to endogenous insulin during therapy with recombinant DNA (rDNA) insulin. Ann Allergy Asthma Immunol 1996;76:253-6.